Literature DB >> 11565793

Characterization of the differential protein expression associated with thermoresistance in human gastric carcinoma cell lines.

P Sinha1, J Poland, M Schnölzer, J E Celis, H Lage.   

Abstract

Resistance to chemotherapeutic agents is one of the major problems faced during palliative therapy of tumor cells. Thus, chemotherapy is frequently combined with other modes of therapy such as radiation therapy and/or hyperthermia. Tumor cells respond to heat stress with development of thermotolerance and the interactions between chemo- and thermoresistance phenomena are not clearly understood. In this paper, we analyze the differential protein expression in vitro in human stomach cancer cells, their chemoresistant and thermoresistant counterparts using proteomics. The immediate aim was to identify sets of proteins that may lead to the development of thermoresistance. Based on these results, we aim to develop functional tests and methods for the modulation of thermoresistance and chemoresistance phenomena that may assist the therapy of inoperable cancers.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11565793     DOI: 10.1002/1522-2683(200108)22:14<2990::AID-ELPS2990>3.0.CO;2-F

Source DB:  PubMed          Journal:  Electrophoresis        ISSN: 0173-0835            Impact factor:   3.535


  10 in total

1.  Efficacy of intraperitoneal thermochemotherapy and immunotherapy in intraperitoneal recurrence after gastrointestinal cancer resection.

Authors:  Qing-Guo Fu; Fan-Dong Meng; Xiao-Dong Shen; Ren-Xuan Guo
Journal:  World J Gastroenterol       Date:  2002-12       Impact factor: 5.742

2.  Identification of proteins differentially expressed in gastric cancer cells with high metastatic potential for invasion to lymph nodes.

Authors:  Do Hee Lee; Youra Lee; Joohyun Ryu; Sung Goo Park; Sayeon Cho; Je-Jung Lee; Chan Choi; Byoung Chul Park
Journal:  Mol Cells       Date:  2011-04-20       Impact factor: 5.034

Review 3.  Use of comparative proteomics to identify potential resistance mechanisms in cancer treatment.

Authors:  Jian-Ting Zhang; Yang Liu
Journal:  Cancer Treat Rev       Date:  2007-09-12       Impact factor: 12.111

4.  Proteomic alteration in gastic adenocarcinomas from Japanese patients.

Authors:  Takahiro Yoshihara; Yoshito Kadota; Yoshiyuki Yoshimura; Yutaka Tatano; Naohiro Takeuchi; Hiroshi Okitsu; Atsushi Umemoto; Takashi Yamauchi; Kohji Itoh
Journal:  Mol Cancer       Date:  2006-12-25       Impact factor: 27.401

5.  Finite volume analysis of temperature effects induced by active MRI implants: 2. Defects on active MRI implants causing hot spots.

Authors:  Martin H J Busch; Wolfgang Vollmann; Dietrich H W Grönemeyer
Journal:  Biomed Eng Online       Date:  2006-05-26       Impact factor: 2.819

6.  Finite volume analysis of temperature effects induced by active MRI implants with cylindrical symmetry: 1. Properly working devices.

Authors:  Martin H J Busch; Wolfgang Vollmann; Jörg Schnorr; Dietrich H W Grönemeyer
Journal:  Biomed Eng Online       Date:  2005-04-08       Impact factor: 2.819

7.  High correlation of the proteome patterns in bone marrow and peripheral blood blast cells in patients with acute myeloid leukemia.

Authors:  Gero Hütter; Anne Letsch; Daniel Nowak; Julia Poland; Pranav Sinha; Eckhard Thiel; Wolf-K Hofmann
Journal:  J Transl Med       Date:  2009-01-15       Impact factor: 5.531

8.  Salivary NUS1 and RCN1 Levels as Biomarkers for Oral Squamous Cell Carcinoma Diagnosis.

Authors:  Sei Ueda; Kengo Hashimoto; Satoru Miyabe; Shogo Hasegawa; Mitsuo Goto; Dai Shimizu; Ichiro Oh-Iwa; Kazuo Shimozato; Toru Nagao; Shuji Nomoto
Journal:  In Vivo       Date:  2020 Sep-Oct       Impact factor: 2.155

9.  Proteomic analysis of differentially expressed proteins in vitamin C-treated AGS cells.

Authors:  Arulkumar Nagappan; Hyeon Soo Park; Kwang Il Park; Jin A Kim; Gyeong Eun Hong; Sang Rim Kang; Jue Zhang; Eun Hee Kim; Won Sup Lee; Chung Kil Won; Gon Sup Kim
Journal:  BMC Biochem       Date:  2013-09-26       Impact factor: 4.059

10.  Downregulation of reticulocalbin-1 differentially facilitates apoptosis and necroptosis in human prostate cancer cells.

Authors:  Xiaofei Liu; Nianzhao Zhang; Dawei Wang; Deyu Zhu; Quan Yuan; Xiulei Zhang; Lilin Qian; Huanmin Niu; Yi Lu; Guijie Ren; Keli Tian; Huiqing Yuan
Journal:  Cancer Sci       Date:  2018-03-31       Impact factor: 6.716

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.